Literature DB >> 26473014

Comparison of the Cellular Composition and Cytokine-Release Kinetics of Various Platelet-Rich Plasma Preparations.

Joo Han Oh1, Woo Kim2, Kyoung Un Park3, Young Hak Roh4.   

Abstract

BACKGROUND: Variations in formulations used to prepare platelet-rich plasmas (PRPs) result in differences in the cellular composition and biomolecular characteristics.
PURPOSE: To evaluate the cellular composition and the cytokine-release kinetics of PRP according to differences in the preparation protocols. STUDY
DESIGN: Controlled laboratory study.
METHODS: Five preparation procedures were performed for 14 healthy subjects, including 2 manual procedures (single-spin [SS] at 900 g for 5 minutes; double-spin [DS] at 900 g for 5 minutes and then 1500 g for 15 minutes) and 3 methods with commercial kits (Arthrex ACP, Biomet GPS, and Prodizen Prosys). After evaluation of cellular composition, each preparation was divided into 4 aliquots and incubated for 1 hour, 24 hours, 72 hours, and 7 days for the assessment of cytokine release over time. The cytokine-release kinetics were evaluated by assessing platelet-derived growth factor (PDGF), transforming growth factor (TGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), interleukin-1 (IL-1), and matrix metalloproteinase-9 (MMP-9) concentrations of each aliquot with bead-based sandwich immunoassay.
RESULTS: The DS PRP had a higher concentration of platelets and leukocytes than did the SS PRP. Every PRP preparation exhibited an increase in PDGF, TGF, VEGF, and FGF release when compared with whole blood samples. The FGF and TGF release occurred quickly and decreased over time, while the PDGF and VEGF release was constant and sustained over 7 days. The PDGF and VEGF concentrations were higher in the DS PRP than in the SS PRP, whereas the TGF and FGF concentrations were higher in the SS PRP than in the DS PRP. Biomet GPS had the highest VEGF and MMP-9 concentrations but the lowest TGF concentration. Arthrex ACP had the highest FGF concentration but the lowest PDGF concentration. Prodizen Prosys had the highest IL-1 concentration and higher PDGF concentration than Arthrex ACP.
CONCLUSION: The DS method generally led to a higher concentration of platelet relative to the SS method. However, the cytokine content was not necessarily proportional to the cellular composition of the PRPs, as the greater content could be different between the SS or DS method depending on the type of cytokine. CLINICAL RELEVANCE: Physicians should select proper PRP preparations after considering their biomolecular characteristics and patient indications.
© 2015 The Author(s).

Entities:  

Keywords:  cell composition; cytokine-release kinetics; platelet-rich plasma; preparations

Mesh:

Substances:

Year:  2015        PMID: 26473014     DOI: 10.1177/0363546515608481

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  36 in total

Review 1.  The use of fat grafting and platelet-rich plasma for wound healing: A review of the current evidence.

Authors:  Oliver J Smith; Gavin Jell; Ash Mosahebi
Journal:  Int Wound J       Date:  2018-11-20       Impact factor: 3.315

Review 2.  Platelet-rich plasma in the foot and ankle.

Authors:  Peter R Henning; Benjamin J Grear
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

Review 3.  Platelet-rich plasma: combinational treatment modalities for musculoskeletal conditions.

Authors:  Isabel Andia; Michele Abate
Journal:  Front Med       Date:  2017-10-18       Impact factor: 4.592

Review 4.  Management of Rotator Cuff Injuries in the Elite Athlete.

Authors:  Leigh J Weiss; Dean Wang; Michael Hendel; Philip Buzzerio; Scott A Rodeo
Journal:  Curr Rev Musculoskelet Med       Date:  2018-03

5.  The Efficacy of Platelet-Rich Plasma on Tendon and Ligament Healing: A Systematic Review and Meta-analysis With Bias Assessment.

Authors:  Xiao Chen; Ian A Jones; Caron Park; C Thomas Vangsness
Journal:  Am J Sports Med       Date:  2017-12-21       Impact factor: 6.202

6.  Platelet-Rich Plasma and Hyaluronic Acid Are Not Synergistic When Used as Biological Adjuncts with Autologous Osteochondral Transplantation.

Authors:  Niall A Smyth; Keir A Ross; Amgad M Haleem; Charles P Hannon; Christopher D Murawski; Huong T Do; John G Kennedy
Journal:  Cartilage       Date:  2017-02-08       Impact factor: 4.634

Review 7.  AAOS Research Symposium Updates and Consensus: Biologic Treatment of Orthopaedic Injuries.

Authors:  Robert F LaPrade; Jason L Dragoo; Jason L Koh; Iain R Murray; Andrew G Geeslin; Constance R Chu
Journal:  J Am Acad Orthop Surg       Date:  2016-07       Impact factor: 3.020

8.  Leucocyte-poor-platelet-rich plasma intra-operative injection in chondral knee injuries improve patients outcomes. A prospective randomized trial.

Authors:  Marcus Vinicius Danieli; João Paulo Fernandes Guerreiro; Alexandre Oliveira Queiroz; Hamilton da Rosa Pereira; Daniele Cristina Cataneo
Journal:  Int Orthop       Date:  2020-09-29       Impact factor: 3.075

9.  Efficacy of Intraoperative Platelet-Rich Plasma Augmentation and Postoperative Platelet-Rich Plasma Booster Injection for Rotator Cuff Healing: A Randomized Controlled Clinical Trial.

Authors:  Bei Liu; Hyeon Jang Jeong; Ji Hyun Yeo; Joo Han Oh
Journal:  Orthop J Sports Med       Date:  2021-06-04

Review 10.  Platelet-rich plasma: a narrative review.

Authors:  Thomas Collins; Dinesh Alexander; Bilal Barkatali
Journal:  EFORT Open Rev       Date:  2021-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.